Markedly elevated serum transaminases in glycogen storage disease type III

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 5, 2011, Pages 621-623

  Karwowski, Christine ^a   Galambos, Csaba ^b   Finegold, David ^a   Shneider, Benjamin L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLO 1,6 GLUCOSIDASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ACUTE GASTROENTERITIS; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIARRHEA; EMERGENCY WARD; ENZYME ANALYSIS; FEMALE; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 3; HEPATOSPLENOMEGALY; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; LABORATORY TEST; LIVER BIOPSY; LIVER CELL DAMAGE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VOMITING;

ALANINE TRANSAMINASE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; INFANT;

EID: 79955562180     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31820e6a55     Document Type: Article

References (13)

1. Shen J, Bao Y, Liu HM, et al. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352-7. (Pubitemid 26255733)
2. Lucchiari S, Donati MA, Melis D, et al. Mutational analysis of the AGL gene: five novel mutations in GSD III patients. Hum Mutat 2003;22:337.
3. Endo Y, Horinishi A, Vorgerd M, et al. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J Hum Genet 2006;51:958-63. (Pubitemid 44800740)
4. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord 2003;4:95-102. (Pubitemid 36182154)
5. Zimakas PJ, Rodd CJ. Glycogen storage disease type III in Inuit children. CMAJ 2005;172:355-8. (Pubitemid 40208723)
6. Oh SH, Park HD, Ki CS, et al. Biochemical and molecular investigation of two Korean patients with glycogen storgae disease type III. Clin Chem Lab Med 2008;46:1245-9.
7. Bernier AV, Sentner CP, Correia CE, et al. Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control. J Inherit Metab Dis 2008;31:729-32.
8. Endo Y, Fateen E, El Shabrawy M, et al. Egyptian glycogen storage disease type III-identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId. Clin Chem Lab Med 2009;47:1233-8.
9. Coleman RA, Winter HS, Wolf B, et al. Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. J Inherit Metab Dis 1992;15:869-81. (Pubitemid 23023190)
10. Kimura T, Ikeda H, Kato M, et al. Severe hypoglycemia in a patient with glycogen storage disease type III induced by infectious mononucleosis. J Inherit Metab Dis 2001;24:873-4. (Pubitemid 34189400)
11. Bhuiyan J, Al Odaib AN, Ozand PT. A simple, rapid test for the differential diagnosis of glycogen storage disease type 3. Clin Chem Acta 2003;335:21-6. (Pubitemid 37338303)
12. Kohli R, Harris DC, Whitington PF. Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy. J Pediatr Gastroenterol Nutr 2005;41:121-4. (Pubitemid 40967367)
13. Kishnani PS, Austin SL, Arn P, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med 2010; 12:446-63.